Ownership history in Bayesian Capital Management, LP Β· 18 quarters on record
This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in MICROCHIP TECHNOLOGY INC (MCHP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Bayesian Capital Management, LP underperformed the S&P 500 by β1.6% annually on this MCHP position. Timing score: 59% (10/17 decisions correct). Average cost basis: $58.93. Maximum drawdown during holding period: β44.7%.
β οΈ Trailed SPY by 1.6% ann. on this position.
17 quarters analyzed
β
Decent timing β more right than wrong on entries and exits.
10 of 17 add/trim decisions correct
Best entry: $26.01 (2016 Q3) Β· Worst: $79.15 (2021 Q4)
πͺ Held through 2 major drawdowns (>20%).
10 adds Β· 8 trims. Bought during 2 of 4 down-price quarters. π More buys than sells across the holding period.
π Bayesian Capital Management, LP has been actively increasing its MCHP allocation β a bullish signal from insiders.
Currently 2.15% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size